
Ep 5: Creative Destruction in Biotech with Shelby Newsad
Shelby Newsad is an early stage venture investor at Compound. I’ve long admired her thesis work in publicly sharing how biotech could unfold over the next decade. In this conversation, we talk about everything from decen
Show notes












